Amphoterin stimulates myogenesis and counteracts the antimyogenic factors basic fibroblast growth factor and S100B via RAGE binding

Molecular and Cellular Biology

Volumn 24, Issue 11, 2004, Pages 4880-4894

  Sorci, Guglielmo ^a   Riuzzi, Francesca ^a   Arcuri, Cataldo ^a   Giambanco, Ileana ^a   Donato, Rosario ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; BASIC FIBROBLAST GROWTH FACTOR; CREATINE KINASE; HIGH MOBILITY GROUP B1 PROTEIN; IMMUNOGLOBULIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 6; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN CDC42; PROTEIN S100B; RAC1 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; DIABETIC ANGIOPATHY; DIABETIC NEUROPATHY; ENZYME ACTIVATION; ENZYME INACTIVATION; ENZYME INDUCTION; GENETIC TRANSFECTION; INFLAMMATION; MUSCLE DEVELOPMENT; NERVE CELL DIFFERENTIATION; NERVE DEGENERATION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; RAT; SKELETAL MUSCLE; TUMOR GROWTH;

ANIMALS; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CDC42 GTP-BINDING PROTEIN; FIBROBLAST GROWTH FACTOR 2; HMGB1 PROTEIN; MAP KINASE KINASE 6; MITOGEN-ACTIVATED PROTEIN KINASES; MUSCLE DEVELOPMENT; MUSCLE, SKELETAL; NERVE GROWTH FACTORS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; RAC1 GTP-BINDING PROTEIN; RATS; RECEPTORS, IMMUNOLOGIC; S100 PROTEINS;

ANIMALIA;

EID: 2442645301     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.24.11.4880-4894.2004     Document Type: Article

References (66)

1. Andres, V., and K. Walsh. 1996. Myogenin expression, cell cycle withdrawal, and phenotypic differentiation are temporally separable events that precede cell fusion upon myogenesis. J. Cell Biol. 132:657-666.
2. Arnold, H. H., and B. Winter. 1998. Muscle differentiation: more complexity to the network of myogenic regulators. Curr. Opin. Genet. Dev. 8:539-544.
3. Arumugam, T., D. M. Simeone, A. M. Schmidt, and C. D. Logsdon. 2004. S100P stimulates cell proliferation and survival via RAGE. J. Biol. Chem. 279:5059-5065. (First published 14 November 2003; 10.1074/jbc.M310124200.)
4. Bennett, A. M., and N. K. Tonks. 1997. Regulation of distinct stages of skeletal muscle differentiation by mitogen-activated protein kinases. Science 278:1288-1291.
5. Bergstrom, D. A., B. H. Penn, A. Strand, R. L. Perry, M. A. Rudnicki, and S. J. Tapscott. 2002. Promoter-specific regulation of MyoD binding and signal transduction cooperate to pattern gene expression. Mol. Cell 9:587-600.
6. Bour, B. A., M. Chakravarti, J. M. West, and S. M. Abmayr. 2000. Drosophila SNS, a member of the immunoglobulin superfamily that is essential for myoblast fusion. Genes Dev. 14:1498-1511.
7. Brett, J., A. M. Schmidt, S. D. Yan, Y. S. Zou, E. Weidman, D. Pinsky, R. Nowygrod, M. Neeper, C. Przysiecki, and A. Shaw. 1993. Survey of the distribution of a newly characterized receptor for advanced glycation end products in tissues. Am. J. Pathol. 143:1699-1712.
8. Coletti, D., E. Yang, G. Marazzi, and D. Sassoon. 2002. TNF inhibits skeletal myogenesis through a PW1-dependent pathway by recruitment of caspase pathways. EMBO J. 21:631-642.
9. Coolican, S. A., D. S. Samuel, D. Z. Ewton, F. J. McWade, and J. R. Florini. 1997. The mitogenic and myogenic actions of insulin-like growth factors utilize distinct signaling pathways. J. Biol. Chem. 272:6653-6662.
10. Cuenda, A., and P. Cohen. 1999. Stress-activated protein kinase 2/p38 and rapamycin-sensitive pathway are required for C2C12 myogenesis. J. Biol. Chem. 274:4341-4346.
11. Donato, R. 2001. S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. Int. J. Biochem. Cell Biol. 33:637-668.
12. Erck, C., C. Meisinger, C. Grothe, and K. Seidl. 1998. Regulation of nerve growth factor and its low-affinity receptor (p75NTR) during myogenic differentiation. J. Cell. Physiol. 176:22-31.
13. Florini, J. R., D. S. Samuel, D. Z. Ewton, C. Kirk, and R. M. Sklar. 1996. Stimulation of myogenic differentiation by a neuregulin, glial growth factor 2. Are neuregulins the long-sought muscle trophic factors secreted by nerves? J. Biol. Chem. 271:12699-12702.
14. Florini, J. R., D. Z. Ewton, and S. A. Coolican. 1996. Growth hormone and the insulin-like growth factor system in myogenesis. Endocr. Rev. 17:481-517.
15. Florini, J. R., K. A. Magri, D. Z. Ewton, P. L. James, K. Grindstaff, and P. S. Rotwein. 1991. "Spontaneous" differentiation of skeletal myoblasts is dependent upon autocrine secretion of insulin-like growth factor-II. J. Biol. Chem. 266:15917-15923.
16. Foulstone, E. J., K. A. Meadows, J. M. Holly, and C. E. Stewart. 2001. Insulin-like growth factors (IGF-I and IGF-II) inhibit C2 skeletal myoblast differentiation and enhance TNF alpha-induced apoptosis. J. Cell. Physiol. 189:207-215.
17. Fujio, Y., K. Guo, T. Mano, Y. Mitsuuchi, J. R. Testa, and K. Walsh. 1999. Cell cycle withdrawal promotes myogenic induction of Akt, a positive modulator of myocyte survival. Mol. Cell. Biol. 19:5073-5082.
18. Guo, K., J. Wang, V. Andres, R. C. Smith, and K. Walsh. 1995. MyoD-induced expression of p21 inhibits cyclin-dependent kinase activity upon myocyte terminal differentiation. Mol. Cell. Biol. 15:3823-3829.
19. Heizmann, C. W., G. Fritz, and B. W. Schafer. 2002. S100 proteins: structure, functions and pathology. Front. Biosci. 7:d1356-1368.
20. Hofmann, M. A., S. Drury, C. Fu, W. Qu, A. Taguchi, Y. Lu, C. Avila, N. Kambham, A. Bierhaus, P. Nawroth, M. F. Neurath, T. Slattery, D. Beach, J. McClary, M. Nagashima, J. Morser, D. Stern, and A. M. Schmidt. 1999. RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell 97:889-901.
21. Hori, O., J. Brett, T. Slattery, R. Cao, J. Zhang, J. X. Chen, M. Nagashima, E. R. Lundh, S. Vijay, D. Nitecki, J. Morser, D. Stern, and A. M. Schmidt. 1995. The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of RAGE and amphoterin in the developing nervous system. J. Biol. Chem. 270:25752-25761.
22. Huttunen, H. J., C. Fages, and H. Rauvala. 1999. Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-B require the cytoplasmic domain of the receptor but different downstream signaling pathways. J. Biol. Chem. 274:19919-19924.
23. Huttunen, H. J., J. Kuja-Panula, G. Sorci, A. L. Agneletti, R. Donato, and H. Rauvala. 2000. Coregulation of neurite outgrowth and cell survival by amphoterin and S100 proteins through RAGE activation. J. Biol. Chem. 275: 40096-40105.
24. Ishihara, K., K. Tsutsumi, S. Kawane, M. Nakajima, and T. Kasaoka. 2003. The receptor for advanced glycation end-products (RAGE) directly binds to ERK by a D-domain-like docking site. FEBS Lett. 550:107-113.
25. Kaliman, P., J. Canicio, X. Testar, M. Palacin, and A. Zorzano. 1999. Insulin-like growth factor-II, phosphatidylinositol 3-kinase, nuclear factor-kappaB and inducible nitric-oxide synthase define a common myogenic signaling pathway. J. Biol. Chem. 274:17437-17444.
26. Kallijarvi, J., M. Haltia, and M. H. Baumann. 2001. Amphoterin includes a sequence motif which is homologous to the Alzheimer's-amyloid peptide (A), forms amyloid fibrils in vitro, and binds avidly to A. Biochemistry 40:10032-10037.
27. Kang, J. S., P. J. Mulieri, C. Miller, D. A. Sassoon, and R. S. Krauss. 1998. CDO, a robo-related cell surface protein that mediates myogenic differentiation. J. Cell Biol. 143:403-413.
28. Kim, D., S. Chi, K. H. Lee, S. Rhee, Y. K. Kwon, C. H. Chung, H. Kwon, and M. S. Kang. 1999. Neuregulin stimulates myogenic differentiation in an autocrine manner. J. Biol. Chem. 274:15395-15400.
29. Kontaridis, M. I., X. Liu, L. Zhang, and A. M. Bennett. 2002. Role of SHP-2 in fibroblast growth factor receptor-mediated suppression of myogenesis in C2C12 myoblasts. Mol. Cell. Biol. 22:3875-3891.
30. Langen, R. C., A. M. Schols, M. C. Kelders, E. F. Wouters, and Y. M. Janssen-Heininger. 2001. Inflammatory cytokines inhibit myogenic differentiation through activation of nuclear factor-B. FASEB J. 15:1169-1180.
31. Lassar, A. B., S. X. Skapek, and B. Novitch. 1994. Regulatory mechanisms that coordinate skeletal muscle differentiation and cell cycle withdrawal. Curr. Opin. Cell Biol. 6:788-794.
32. Li, Y., B. Jiang, W. Y. Ensign, P. K. Vogt, and J. Han. 2000. Myogenic differentiation requires signalling through both phosphatidylinositol 3-kinase and p38 MAP kinase. Cell. Signal. 12:751-757.
33. Ludolph, D. C., and S. F. Konleczny. 1995. Transcription factor families: muscling in on the myogenic program. FASEB J. 9:1595-1604.
34. Lue, L. F., D. G. Walker, L. Brachova, T. G. Beach, J. Rogers, A. M. Schmidt, D. M. Stern, and S. D. Yan. 2001. Involvement of microglial receptor for advanced glycation end products (RAGE) in Alzheimer's disease: identification of a cellular activation mechanism. Exp. Neurol. 171:29-45.
35. Massague, J., S. Cheifetz, T. Endo, and B. Nadal-Ginard. 1986. Type beta transforming growth factor is an inhibitor of myogenic differentiation. Proc. Natl. Acad. Sci. USA 83:8206-8210.
36. Meriane, M., P. Roux, M. Primig, P. Fort, and C. Gauthier-Rouviere. 2000. Critical activities of Racl and Cdc42Hs in skeletal myogenesis: antagonistic effects of JNK and p38 pathways. Mol. Biol. Cell 11:2513-2528.
37. Miller, S. C., H. Ito, H. M. Blau, and F. M. Torti. 1988. Tumor necrosis factor inhibits human myogenesis in vitro. Mol. Cell. Biol. 8:2295-2301.
38. Muller, S., P. Scaffidi, B. Degryse, T. Bonaldi, L. Ronfani, A. Agresti, M. Beltrame, and M. E. Bianchi. 2001. The double life of HMGB1 chromatin protein: architectural factor and extracellular signal. EMBO J. 20:4337-4340.
39. Olson, E. N. 1992. Interplay between proliferation and differentiation within the myogenic lineage. Dev. Biol. 154:261-272.
40. Olson, E. N., G. Spizz, and M. A. Tainsky. 1987. The oncogenic forms of N-ras or H-ras prevent skeletal myoblast differentiation. Mol. Cell. Biol. 7:2104-2111.
41. Patel, B. N., and D. L. Van Vactor. 2002. Axon guidance: the cytoplasmic tail. Curr. Opin. Cell Biol. 14:221-229.
42. Pena, T. L., S. H. Chen, S. F. Konieczny, and S. G. Rane. 2000. Ras/MEK/ERK up-regulation of the fibroblast KCa channel FIK is a common mechanism for basic fibroblast growth factor and transforming growth factor-beta suppression of myogenesis. J. Biol. Chem. 275:13677-13682.
43. Perry, R. L., M. H. Parker, and M. A. Rudnicki. 2001. Activated MEK1 binds the nuclear MyoD transcriptional complex to repress transactivation. Mol. Cell 8:291-301.
44. Puri, P. L., Z. Wu, P. Zhang, L. D. Wood, K. S. Bhakta, J. Han, J. R. Feramisco, M. Karin, and J. Y. J. Wang. 2000. Induction of terminal differentiation by constitutive activation of p38 MAP kinase in human rhabdomyosarcoma cells. Genes Dev. 14:574-584.
45. Rende, M., E. Brizi, J. Conner, S. Treves, K. Censier, C. Provenzano, G. Taglialatela, P. P. Sanna, and R. Donato. 2000. Nerve growth factor (NGF) influences differentiation and proliferation of myogenic cells in vitro via TrKA. Int. J. Dev. Neurosci. 18:869-885.
46. Ruiz-Gomez, M., N. Coutts, A. Price, M. V. Taylor, and M. Bate. 2000. Drosophila dumbfounded: a myoblast attractant essential for fusion. Cell 102:189-198.
47. Sakaguchi, T., S. F. Yan, S. D. Yan, D. Belov, L. L. Rong, M. Sousa, M. Andrassy, S. P. Marso, S. Duda, B. Arnold, B. Liliensiek, P. P. Nawroth, D. M. Stern, A. M. Schmidt, and Y. Naka. 2003. Central role of RAGE-dependent neointimal expansion in arterial restenosis. J. Clin. Investig. 111: 959-972.
48. Schmidt, A. M., S. D. Yan, S. F. Yan, and D. Stern. 2000. The biology of the receptor for advanced glycation end products and its ligands. Biochim. Biophys. Acta 1498:99-111.
49. Schmidt, A. M., S. D. Yan, S. F. Yan, and D. M. Stern. 2001. The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses. J. Clin. Investig. 108:949-955.
50. Seidl, K., C. Erck, and A. Buchberger. 1998. Evidence for the participation of nerve growth factor and its low-affinity receptor (p75NTR) in the regulation of the myogenic program. J. Cell. Physiol. 176:10-21.
51. Sorci, G., F. Riuzzi, A. L. Agneletti, C. Marchetti, and R. Donato. 2003. S100B inhibits myogenic differentiation and myotube formation in a RAGE-independent manner. Mol. Cell. Biol. 23:4870-4881.
52. Sorci, G., R. Bianchi, I. Giambanco, M. G. Rambotti, and R. Donato. 1999. Replicating myoblasts and fused myotubes express the calcium-modulated proteins S100A1 and S100B. Cell Calcium 25:93-106.
53. Srikrishna, G., H. J. Huttunen, L. Johansson, B. Weigle, Y. Yamaguchi, H. Rauvala, and H. H. Freeze. 2002. N-glycans on the receptor for advanced glycation end products influence amphoterin binding and neurite outgrowth. J. Neurochem. 80:998-1008.
54. Taguchi, A., D. C. Blood, G. del Toro, A. Canet, D. C. Lee, W. Qu, N. Tanji, Y. Lu, E. Lalla, C. Fu, M. A. Hofmann, T. Kislinger, M. Ingram, A. Lu, H. Tanaka, O. Hori, S. Ogawa, D. M. Stern, and A. M. Schmidt. 2000. Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases. Nature 405:354-360.
55. Tamir, Y., and E. Bengal. 2000. Phosphoinositide 3-kinase induces the transcriptional activity of MEF2 proteins during muscle differentiation. J. Biol. Chem. 275:34424-34432.
56. Tortorella, L. L., D. J. Milasincic, and P. F. Pilch. 2001. Critical proliferation-independent window for basic fibroblast growth factor repression of myogenesis via the p42/p44 MAPK signaling pathway. J. Biol. Chem. 276: 13709-13717.
57. Tureckova, J., E. M. Wilson, J. L. Cappalonga, and P. Rotwein. 2001. Insulin-like growth factor-mediated muscle differentiation: collaboration between phosphatidylinositol 3-kinase-Akt-signaling pathways and myogenin. J. Biol. Chem. 276:39264-39270.
58. Wang, H., H. Yang, C. J. Czura, A. E. Sama, and K. J. Tracey. 2001. HMGB1 as a late mediator of lethal systemic inflammation. Am. J. Respir. Crit. Care Med. 164:1768-1773.
59. Weintraub, H. 1993. The MyoD family and myogenesis: redundancy, networks, and thresholds. Cell 75:1241-1244.
60. Wendt, T., L. Bucciarelli, W. Qu, Y. Lu, S. F. Yan, D. M. Stern, and A. M. Schmidt. 2002. Receptor for advanced glycation end products (RAGE) and vascular inflammation: insights into the pathogenesis of macrovascular complications in diabetes. Curr. Atheroscler. Rep. 4:228-237.
61. Winter, B., and H.-H. Arnold. 2000. Activated Rak kinase inhibits muscle cell differentiation through a MEF2-dependent mechanism. J. Cell Sci. 113: 4211-4220.
62. Wu, Z., P. J. Woodring, K. S. Bhakta, K. Tamura, F. Wen, J. R. Feramisco, M. Karin, J. Y. J. Wang, and P. L. Puri. 2000. p38 and extracellular signal-regulated kinases regulate the mycgenic program at multiple steps. Mol. Cell. Biol. 20:3951-3964.
63. Xu, D., and J. M. Kyriakis. 2003. Phosphatidylinositol 3′-kinase-dependent activation of renal mesangial cell Ki-Ras and ERK by advanced glycation end products. J. Biol. Chem. 278:39349-39355.
64. Yan, S. D., H. Zhu, J. Fu, S. F. Yan, A. Roher, W. W. Tourtellotte, T. Rajavashisth, X. Chen, G. C. Godman, D. Stern, and A. M. Schmidt. 1997. Amyloid-beta peptide-receptor for advanced glycation end product interaction elicits neuronal expression of macrophage-colony stimulating factor: a proinflammatory pathway in Alzheimer disease. Proc. Natl. Acad. Sci. USA 94:5296-5301.
65. Yan, S. D., X. Chen, J. Fu, M. Chen, H. Zhu, A. Roher, T. Slattery, L. Zhao, M. Nagashima, J. Morser, A. Migheli, P. Nawroth, D. Stern, and A. M. Schmidt. 1996. RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease. Nature 382:685-691.
66. Zetser, A., E. Gredinger, and E. Bengal. 1999. p38 mitogen-activated protein kinase pathway promotes skeletal muscle differentiation. Participation of the Mef2c transcription factor. J. Biol. Chem. 274:5193-5200.